EClinicalMedicine May 2025 PMID 40256773

Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trial.

Sean W X Ong, Ruxandra Pinto, Asgar Rishu, Steven Y C Tong, Robert J Commons, John M Conly, Gerald A Evans, Michael Fralick, Christopher Kandel, Philippe R S Lagacé-Wiens, Todd C Lee, Sylvain A Lother, Derek R MacFadden, John C Marshall, Valérie Martel-Laferrière

Download social card

Mentions

2
Peak: 1 in Apr 2025
across 2 sources since Apr 2025

Extended reach

3,460
potential audience

Total likes

1

Video views

14

Mentions per month

Apr 2025 – Sep 2025

Where it's discussed

  • X / Twitter1 posts
  • YouTube1 videos

AI synopsis

What people are saying

Many posts explore the implications of the study, with expressions like 'this could change treatment protocols' indicating broad interest and appreciation for the research's significance, supported by mentions of the clinical decision rules and the robustness of the data. The variation in tone—from cautious optimism to critical reflection—reflects diverse levels of engagement and perceived impact across different users.

AgreementModerate agreement

Most discussions acknowledge the validity of the findings, with some emphasizing the importance of optimizing antibiotic durations.

InterestHigh interest

The topic clearly captures interest, as evidenced by comments highlighting the significance of treatment duration and implications for patient care.

EngagementModerate engagement

Participants reference specific study details, models used, and potential clinical implications, indicating moderate engagement.

ImpactModerate impact

While some recognize the study’s potential to influence clinical practices, others focus on confirming existing guidelines, leading to moderate impact scores.

Abstract in brief

  • The BALANCE trial found that a 7-day antibiotic treatment for uncomplicated non-bacterial bloodstream infections is just as effective as a 14-day treatment, but the researchers wanted to see if specific patient groups might still benefit from longer treatment.
  • They analyzed data from 3,581 patients using various clinical decision rules to assess the impact of treatment duration on 90-day mortality, but none of the rules showed significant differences between the two treatment durations for different risk groups.
  • Overall, the study concluded that the 7-day treatment is adequate for most patients, as the clinical decision rules did not identify any subgroup that would benefit from extending treatment to 14 days.

Top posts

Most liked on X and Bluesky
Wellington ICU
@WellingtonICU · X

Second is in The Lancet: Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trial: https://t.co/6JccQYsIHo https://t.co/vLDkW4yMjT

Apr 11, 2025 · 1 like · 3,447 followers View post →

All mentions

Wellington ICU
@WellingtonICU · X

Second is in The Lancet: Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trial: https://t.co/6JccQYsIHo https://t.co/vLDkW4yMjT

Apr 11, 2025 · 1 like · 3,447 followers View post →